Treatment of Patients with Metastatic Renal Cell Carcinoma: Results of Two Clinical Phase II Studies with Alpha-2-Interferon Versus Alpha-2-Interferon Plus Vinblastine or Gamma Interferon in 55 Patients
19874 citationsJournal Article
Field-Weighted Citation Impact: 0.50
Treatment of Patients with Metastatic Renal Cell Carcinoma: Results of Two Clinical Phase II Studies with Alpha-2-Interferon Versus Alpha-2-Interferon Plus Vinblastine or Gamma Interferon in 55 Patients | Researchclopedia